These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11334936)

  • 1. Transporters in African trypanosomes: role in drug action and resistance.
    de Koning HP
    Int J Parasitol; 2001 May; 31(5-6):512-22. PubMed ID: 11334936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and mode of action of drugs used against sleeping sickness.
    Denise H; Barrett MP
    Biochem Pharmacol; 2001 Jan; 61(1):1-5. PubMed ID: 11137702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.
    Baker N; de Koning HP; Mäser P; Horn D
    Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput decoding of antitrypanosomal drug efficacy and resistance.
    Alsford S; Eckert S; Baker N; Glover L; Sanchez-Flores A; Leung KF; Turner DJ; Field MC; Berriman M; Horn D
    Nature; 2012 Jan; 482(7384):232-6. PubMed ID: 22278056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.
    Sanderson L; Dogruel M; Rodgers J; Bradley B; Thomas SA
    J Neurochem; 2008 Nov; 107(4):1136-46. PubMed ID: 18823367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Updates on Development of Drug Molecules for Human African Trypanosomiasis.
    Singh Grewal A; Pandita D; Bhardwaj S; Lather V
    Curr Top Med Chem; 2016; 16(20):2245-65. PubMed ID: 27072715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
    Dukes P
    Trans R Soc Trop Med Hyg; 1984; 78(6):711-25. PubMed ID: 6241967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes.
    Bridges DJ; Gould MK; Nerima B; Mäser P; Burchmore RJ; de Koning HP
    Mol Pharmacol; 2007 Apr; 71(4):1098-108. PubMed ID: 17234896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

  • 14. Eflornithine for the treatment of human African trypanosomiasis.
    Burri C; Brun R
    Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma evansi: in vivo and in vitro determination of trypanocide resistance profiles.
    Zhang ZQ; Giroud C; Baltz T
    Exp Parasitol; 1993 Dec; 77(4):387-94. PubMed ID: 8253152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA aptamers as potential pharmaceuticals against infections with African trypanosomes.
    Göringer HU; Homann M; Zacharias M; Adler A
    Handb Exp Pharmacol; 2006; (173):375-93. PubMed ID: 16594626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Steverding D; Rushworth SA
    Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.